SCHEMBL5002673

SCHEMBL5002673

O=C1NCCn2nc(-c3ccnc(-c4ccc5cc[nH]c5c4)c3)cc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.58
PRKDC P78527 2/20 0.45
KDM4C Q9H3R0 1/20 0.39
BRAF P15056 1/20 0.38
MAPKAPK2 P49137 3/20 0.38
PIM1 P11309 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
MAPK9 P45984 1/20 0.37
BACE1 P56817 1/20 0.35
PIK3C3 Q8NEB9 1/20 0.35
MTOR P42345 2/20 0.34
PIK3CA P42336 2/20 0.34
PIK3CD O00329 1/20 0.34
ABL1 P00519 1/20 0.34
EGFR P00533 1/20 0.34
HCK P08631 1/20 0.34
SRC P12931 1/20 0.34
KDR P35968 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4991253 0.92 CDC7 (0.57) CDC7PRKDCBRAFMAPKAPK2PIM1
SCHEMBL14188396 0.84 CDC7 (0.55) CDC7MAPKAPK2PIM1PIM2PIK3C3
SCHEMBL14188405 0.82 CDC7 (0.66) CDC7MAPKAPK2PIM1PIM2PIK3C3
SCHEMBL4716033 0.82 CDC7 (0.66) CDC7MAPKAPK2PIM1PIM2PIK3C3
SCHEMBL5000428 0.82 CDC7 (0.62) CDC7MAPKAPK2PIM1PIM2PIK3C3
SCHEMBL14188432 0.81 CDC7 (0.61) CDC7KDM4CMAPKAPK2PIM1PIM2
SCHEMBL14188402 0.81 CDC7 (0.61) CDC7MAPKAPK2PIM1PIM2PIK3C3
SCHEMBL14188367 0.81 CDC7 (0.55) CDC7MAPKAPK2PIM1MTORPIK3CA
SCHEMBL14188427 0.81 CDC7 (0.54) CDC7MAPKAPK2PIM1PIM2PIK3C3
SCHEMBL14188386 0.81 CDC7 (0.63) CDC7MAPKAPK2PIM1PIM2PIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS MKNK2, MAPKAPK2, MAP3K2 CDC7 487/4885PRKDC 122/4885KDM4C 3885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.